L. Di

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

K. Gajiwala, A. Kalgutkar, P. Verhoest, 2021, Science.

Characterization and comparative evaluation of a structurally unique PAI‐1 inhibitor exhibiting oral in‐vivo efficacy

N. Gorlatova, D. Lawrence, H. Elokdah, 2004, Journal of thrombosis and haemostasis : JTH.

Proteasome and Autophagy Pathway in Corneal Epithelial Cells with Limbal Stem Cell Deficiency

O. Joan, N. Robert, L. Di, 2020 .